首页|期刊导航|中华医学杂志(英文版)|Pancreatic ductal adenocarcinoma chemoresistance:From metabolism reprogramming to novel treatment
中华医学杂志(英文版)2024,Vol.137Issue(4):408-420,13.DOI:10.1097/CM9.0000000000002758
Pancreatic ductal adenocarcinoma chemoresistance:From metabolism reprogramming to novel treatment
Pancreatic ductal adenocarcinoma chemoresistance:From metabolism reprogramming to novel treatment
摘要
关键词
Pancreatic cancer/Drug resistance/Drug development/Signal transductionKey words
Pancreatic cancer/Drug resistance/Drug development/Signal transduction引用本文复制引用
Jingcheng Zhang,Yutong Wang,Lejunzi Wang,Lei You,Taiping Zhang..Pancreatic ductal adenocarcinoma chemoresistance:From metabolism reprogramming to novel treatment[J].中华医学杂志(英文版),2024,137(4):408-420,13.基金项目
This study was supported by grants from the National Natural Science Foundation of China(Nos.81772639 and 81802475)and Natural Science Foundation of Beijing(No.7192157). (Nos.81772639 and 81802475)